SUN-741 - Gensci144, A Novel SLC6A19 Inhibitor, Demonstrates Renoprotective Efficacy in A Humanized SLC6A19 Mouse Model of Aristolochic Acid Nephropathy

Abstract Poster Presenter(s)

• JM

  Jing Ma, GS11592

  Changchun Genescience Pharmaceuticals Co., Ltd., Shanghai, China
  Shanghai, China (People's Republic)

Co-Author(s)

• NL

  NA LIU, scientist

  Changchun Genescience Pharmaceuticals Co., Ltd., Shanghai, China
  Shanghai, China (People's Republic)

Senior Author/Primary Investigator(s)

• XW

  XIAOZHEN WANG, n/a

  VP
  Changchun Genescience Pharmaceuticals Co., Ltd., Shanghai, China
  Shanghai, China (People's Republic)

Co-Author(s)

• DS

  Dandan Sun, NA

  Changchun Genescience Pharmaceuticals Co., Ltd., Shanghai, China
  Shanghai, China (People's Republic)
• MX

  Mingcheng Xu, NA

  Changchun Genescience Pharmaceuticals Co., Ltd., Shanghai, China
  Shanghai, China (People's Republic)
• LZ

  Lulu Zhang, NA

  Changchun Genescience Pharmaceuticals Co., Ltd., Shanghai, China
  Shanghai, China (People's Republic)
• XC

  Xin Chen, NA

  Changchun Genescience Pharmaceuticals Co., Ltd., Shanghai, China
  Shanghai, China (People's Republic)
• KZ

  Kaili Zhang, NA

  Changchun Genescience Pharmaceuticals Co., Ltd., Shanghai, China
  Shanghai, China (People's Republic)
• YX

  Yuanfeng Xia, n/a

  Changchun GenSci Pharma
  Shanghai, China (People's Republic)
• HZ

  Haizhou Zhang, Ph.D.

  GeneScience Pharmaceuticals
  shanghai, China (People's Republic)